Connor, Clark & Lunn Investment Management (CC&L)’s Amedisys AMED Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-22,338
| Closed | -$5.47M | – | 1025 |
|
2021
Q2 | $5.47M | Buy |
22,338
+7,853
| +54% | +$1.92M | 0.03% | 337 |
|
2021
Q1 | $3.84M | Buy |
14,485
+2,568
| +22% | +$680K | 0.02% | 420 |
|
2020
Q4 | $3.5M | Sell |
11,917
-1,930
| -14% | -$566K | 0.02% | 405 |
|
2020
Q3 | $3.27M | Buy |
13,847
+9,619
| +228% | +$2.27M | 0.02% | 379 |
|
2020
Q2 | $839K | Buy |
+4,228
| New | +$839K | 0.01% | 654 |
|
2019
Q4 | – | Sell |
-8,025
| Closed | -$1.05M | – | 917 |
|
2019
Q3 | $1.05M | Sell |
8,025
-23,525
| -75% | -$3.08M | 0.01% | 535 |
|
2019
Q2 | $3.83M | Buy |
31,550
+8,325
| +36% | +$1.01M | 0.02% | 326 |
|
2019
Q1 | $2.86M | Buy |
23,225
+15,425
| +198% | +$1.9M | 0.02% | 357 |
|
2018
Q4 | $913K | Buy |
7,800
+3,975
| +104% | +$465K | 0.01% | 569 |
|
2018
Q3 | $478K | Buy |
+3,825
| New | +$478K | ﹤0.01% | 713 |
|
2016
Q2 | – | Sell |
-15,775
| Closed | -$763K | – | 861 |
|
2016
Q1 | $763K | Sell |
15,775
-42,350
| -73% | -$2.05M | 0.01% | 504 |
|
2015
Q4 | $2.29M | Sell |
58,125
-61,025
| -51% | -$2.4M | 0.02% | 312 |
|
2015
Q3 | $4.52M | Sell |
119,150
-34,350
| -22% | -$1.3M | 0.04% | 213 |
|
2015
Q2 | $6.1M | Sell |
153,500
-21,700
| -12% | -$862K | 0.06% | 139 |
|
2015
Q1 | $4.69M | Sell |
175,200
-45,900
| -21% | -$1.23M | 0.04% | 157 |
|
2014
Q4 | $6.49M | Sell |
221,100
-21,900
| -9% | -$643K | 0.05% | 141 |
|
2014
Q3 | $4.9M | Sell |
243,000
-7,800
| -3% | -$157K | 0.04% | 138 |
|
2014
Q2 | $4.47M | Sell |
250,800
-16,500
| -6% | -$294K | 0.03% | 166 |
|
2014
Q1 | $4.39M | Buy |
267,300
+41,700
| +18% | +$685K | 0.03% | 174 |
|
2013
Q4 | $3.51M | Buy |
225,600
+60,200
| +36% | +$936K | 0.03% | 195 |
|
2013
Q3 | $2.93M | Buy |
165,400
+50,000
| +43% | +$885K | 0.03% | 159 |
|
2013
Q2 | $1.41M | Buy |
+115,400
| New | +$1.41M | 0.01% | 230 |
|